Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 52 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

48%

25 trials in Phase 3/4

Results Transparency

0 of 35 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

Phase 1

21(41.2%)

Phase 3

19(37.3%)

Phase 4

6(11.8%)

Phase 2

4(7.8%)

N/A

1(2.0%)

51Total

Phase 1(21)

Phase 3(19)

Phase 4(6)

Phase 2(4)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (52)

Showing 20 of 52 trials

NCT05365425Phase 4Recruiting

Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Role: collaborator

NCT07444762Phase 3Completed

Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

Role: lead

NCT07382661Phase 1Not Yet Recruiting

Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin

Role: lead

NCT07364877Phase 1Enrolling By Invitation

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

Role: lead

NCT07364838Phase 1Completed

Study to Evaluate the Effect of Food on the Pharmacokinetics and Pharmacodynamics Characteristics in Healthy Adult Volunteers

Role: lead

NCT07364851Phase 1Not Yet Recruiting

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

Role: lead

NCT07349589Phase 1Not Yet Recruiting

Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers

Role: lead

NCT07343245Phase 1Recruiting

A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

Role: lead

NCT07319520Phase 2Completed

Clinical Trial to Evaluate the Efficacy and Safety of DW4902

Role: lead

NCT07319559Phase 1Completed

Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

Role: lead

NCT07168473Phase 3Recruiting

Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma

Role: lead

NCT07060209Phase 1Recruiting

Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults

Role: collaborator

NCT07032558Phase 1Recruiting

Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions

Role: collaborator

NCT07093697Phase 3Completed

A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212

Role: lead

NCT07076056Phase 3Completed

Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2

Role: lead

NCT06767774Phase 4Recruiting

Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

Role: collaborator

NCT06147908Phase 1Completed

Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R

Role: lead

NCT05970679Phase 3Completed

Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

Role: lead

NCT05683951Phase 3Completed

Clinical Trial to Evaluate the Efficacy and Safety of DWKH

Role: lead

NCT05214677Phase 1Completed

A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

Role: lead